1 |
Chen K, Xia Y, Wang H, et al. Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial [J]. PloS One, 2013, 8(2):e57397.
|
2 |
Liu K, Ji B, Zhang W, et al. Comparison of iodine-125 seed implantation and pancreaticoduodenectomy in the treatment of pancreatic cancer [J]. Int J Med Sci, 2014, 11(9):893.
|
3 |
Robert A, Doralina L, Costantino B, et al. NCCN clinical practice guidelines in Oncology: Adult Cancer Pain, Version 2. 2016 [J]. J Natl Compr Canc Netw, 2016.
URL
|
4 |
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009, 45(2):2495-2501.
|
5 |
Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [J]. Ann Surg, 2000, 232(1):10-24.
|
6 |
Zheng L, Lv X, Shi Y, et al. 125I interstitial brachytherapy for the treatment of myoepithelial carcinoma of the oral and maxillofacial region [J]. Brachytherapy, 2016, 15(2):240-245.
|
7 |
Yang M, Fang Z, Yan Z, et al. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial [J]. J Cancer Res Clin Oncol, 2014, 140(4):211-219.
|
8 |
郑孝文,赵永福,唐哲等. 超声引导下肝恶性肿瘤射频消融治疗的疗效及其影响因素 [J].中华肝脏病杂志, 2016, 24(1):69-73.
|
9 |
杨伟萍,姚波,韦长元, 等. 超声引导下125I放射性粒子植入治疗原发性肝癌的临床观察[J]. 中华肿瘤防治杂志, 2012, 19(12):928-930.
|
10 |
谢正强,张丽,殷娟, 等. 超声引导下125I粒子植入治疗中晚期肝癌 [J]. 现代肿瘤医学, 2011, 19(2):314-315.
|
11 |
刘洋,盛波,姜凯, 等. 术中放射性粒子植入治疗晚期胰腺癌的疗效 [J]. 中华肝胆外科杂志, 2014, 20(6):446-448.
|
12 |
Han Q, Deng M, Lv Y, et al. Survival of patients with advanced pancreatic cancer after iodine125 seeds implantation brachytherapy: A meta-analysis [J]. Medicine (Baltimore), 2017, 96(5):e5719.
|
13 |
李玲,郎景和,樊庆泊, 等. 原发性腹膜后肿瘤的研究进展 [J]. 中华妇产科杂志, 2015, 50(1):76-78.
|
14 |
Patel MI, Motzer RJ, Sheinfeld J. Management of recurrence and follow-up strategies for patients with seminoma and selected high-risk groups [J]. Urol Clin North Am, 2003, 30(4):803-817.
|
15 |
Hirasaki S, Moriwaki T, Tsuzuki T, et al. Extragonadal retroperitoneal embryonal carcinoma successfully treated with chemotherapy [J]. Intern Med, 2003, 42(11):1122-1126.
|
16 |
李留峥,于杰,左峻林, 等. 复发性腹膜后肿瘤综合治疗26例体会 [J]. 临床肿瘤学杂志, 2006, 11(6):448-449, 454.
|
17 |
徐少明. 复发性腹膜后肿瘤的综合治疗 [J]. 中国实用外科杂志, 2002, 22(8):463-464.
|
18 |
Yang B, Guo W, Lan T, et al. CT-guided 125I seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy [J]. Exp Ther Med, 2016, 12(6):3843-3850.
|
19 |
Wang Z. CT-guided radioactive 125I seed implantation therapy of symptomatic retroperitoneal lymph node metastases [J]. Cardiovasc Intervent Radiol, 2014, 37(1):125-31.
|
20 |
Yao L, Jiang Y, Jiang P, et al. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy [J]. Brachytherapy, 2015, 14(5):662-669.
|
21 |
徐静,梅铭惠,陈谦, 等. 术中组织间植入125I粒子治疗肝恶性肿瘤 [J]. 中华实验外科杂志, 2005, 22(3):368-369.
|
22 |
李勇,冯贤松. 125I粒子术中植入治疗腹腔恶性肿瘤 [J]. 腹部外科, 2005, 18(2):96-97.
|